BioPharma Resources

Drug Trial Radar · NCT04419649

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Aug 19, 2020

Primary completion

Oct 30, 2029

Study completion Oct 30, 2031

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Jun 5, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main aim of this study is to learn how safe elritercept is and how well adults with anemia associated with lower-risk MDS tolerate treatment with different doses of elritercept. Other aims are to learn how safe elritercept is by looking at how many participants have MDS that worsens during the study and learn about the effects of elritercept on anemia linked to MDS. The study will also look to learn how elritercept affects the production of healthy RBCs.

Conditions

  • Myelodysplastic Syndromes
  • Cytopenia

Interventions

  • ElriterceptDrug

    Elritercept SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: From treatment initiation to end of study (up to 11.2 years)

Locations

53 sites in 8 countries. Site status is shown where the registry gives one.

  • Genesis Cancer and Blood Institute

    Hot Springs, Arkansas · Recruiting

  • City of Hope National Medical Center

    Duarte, California · Recruiting

  • University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC)

    Miami, Florida · Recruiting

  • H. Lee Moffitt Cancer Center and Research Center

    Tampa, Florida · Recruiting

  • The Center for Cancer and Blood Disorders (CCBD) - Bethesda

    Bethesda, Maryland · Recruiting

  • Karmanos Cancer Institute at Mclaren Greater Lansing

    Lansing, Michigan · Completed

  • Hackensack Medical Center

    Hackensack, New Jersey · Recruiting

  • New York Cancer and Blood

    Shirley, New York · Recruiting

  • University of Pittsburgh Medical Health Center

    Pittsburgh, Pennsylvania · Completed

  • Baptist Clinical Research Institute

    Memphis, Tennessee · Recruiting

  • Univ of Texas MD Anderson Cancer Center, Division of Cancer Medicine

    Houston, Texas · Recruiting

  • Border Medical Oncology Research

    Albury, New South Wales, Australia · Recruiting

  • Tweed Hospital

    Tweed Heads, New South Wales, Australia · Recruiting

  • Westmead Hospital

    Westmead, New South Wales, Australia · Recruiting

  • Townsville University Hospital

    Douglas, Queensland, Australia · Completed

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Flinders Medical Centre

    Bedford Park, South Australia, Australia · Recruiting

  • Boxhill Hospital

    Box Hill, Victoria, Australia · Recruiting

  • University Hospital Geelong

    Geelong, Victoria, Australia · Recruiting

  • Austin Health

    Heidelberg, Victoria, Australia · Recruiting

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia · Recruiting

  • St Vincent's Hospital Melbourne

    Melbourne, Victoria, Australia · Recruiting

  • Ballarat Oncology & Haematology Service

    Wendouree, Victoria, Australia · Completed

  • Fakultni nemocnice Brno

    Brno, Czechia · Completed

  • Fakultni nemocnice Kralovske Vinohrady

    Prague, Czechia · Recruiting

  • Vseobecna Fakultni Nemocnice Praha

    Prague, Czechia · Completed

  • CHU Angers - Hopital Hotel Dieu

    Angers, France · Completed

  • Centre Hospitalier de la Region dAnnecy

    Épagny, France · Completed

  • CHU de Nantes - Hotel Dieu

    Nantes, France · Recruiting

  • CHU Nice - Hopital de l'Archet 1

    Nice, France · Recruiting

  • Hopital Saint-Louis

    Paris, France · Recruiting

  • CH Rene-Dubos

    Pontoise, France · Recruiting

  • CHU de Bordeaux - Hopital Haut-Leveque

    Talence, France · Recruiting

  • Klinikum Bayreuth GmbH

    Bayreuth, Germany · Recruiting

  • Charite-Campus Benjamin Franklin

    Berlin, Germany · Not yet recruiting

  • Praxis am Volkspark Berlin

    Berlin, Germany · Not yet recruiting

  • University Hospital Bonn

    Bonn, Germany · Not yet recruiting

  • Marien Hospital Dusseldorf GMBH

    Düsseldorf, Germany · Recruiting

  • Universitaetsklinikum Duesseldorf AoeR

    Düsseldorf, Germany · Completed

  • Klinikum Esslingen GmbH

    Esslingen am Neckar, Germany · Recruiting

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.